Issue Price
₹170
Per Share
GMP
NIL
Grey Market
Est. Listing
₹170
Expected Price
Min. Application
₹272,000
2 lots × 800 shares
Incorporated in 1993, Bajaj Healthcare Ltd is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs).Currently they operate five (5) manufacturing units. Company's present product portfolio consists of various APIs in the therapeutic categories of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal & Bacteriostatic, Diuretic & Vasodilator, Mineral& Nutritional supplements, Bronchodilater / Anti-asthmatic and Nootropics. Their Formulations unit manufactures tablets, capsules and sachets for their own brands as well as under Loan License (job work) for other pharmaceutical companies. Currently, they manufacture formulations for GlaxoSmithKline Pharmaceuticals Limited (GSK) and USV Limited (USV) on a Loan License basis.Bajaj Healthcare supply their APIs and FDFs both domestically and exporting to various countries in regions like, Europe, USA, Australia, Africa, South America, etc.
Bajaj Healthcare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 91,200 | — | ₹1.55 Cr | — |
| TOTAL | 1,817,600 | 100.00% | ₹30.90 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 800 | ₹136,000 |
| Retail (Max) | 13 | 10,400 | ₹1,768,000 |
| sNII (Min) | 14 | 11,200 | ₹1,904,000 |
| bNII (Min) | 68 | 54,400 | ₹9,248,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |